Abstract
Mutations in the BRCA1 and BRCA2 genes predispose women to breast and ovarian cancer. The large majority of the alterations identified in these genes are point mutations and small insertion/deletion. However, an increasing number of large genomic rearrangements (LGRs) are being identified, especially in BRCA1. To date just a few large genomic rearrangements of BRCA1 gene have been reported in Poland. Technical limitations of conventional PCR-based methods are cause that gross rearrangements can be overlooked. It has been suggested that about 30% of mutations in the BRCA1 gene are missed by standard mutation detection methods. We screened for LGRs in BRCA1 and BRCA2 genes by Multiplex Ligation-dependent Probe Amplification (MLPA) in 200 unrelated patients with strong family history of breast and/or ovarian cancer negative for BRCA1 Polish founder mutation. We identified 3 different LGRs in BRCA1 gene. No large LGRs were detected in BRCA2 genes.
Highlights
Mutations in the BRCA1 and BRCA2 genes predispose women to breast and ovarian cancer
To date just a few large genomic rearrangements of BRCA1 gene have been reported in Poland
It has been suggested that about 30% of mutations in the BRCA1 gene are missed by standard mutation detection methods
Summary
Mutations in the BRCA1 and BRCA2 genes predispose women to breast and ovarian cancer. Large genomic rearrangements in BRCA1 and BRCA2 genes in breast and ovarian cancer families in Poland From Annual Conference on Hereditary Cancers 2011 Szczecin, Poland.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.